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The  present  study  was designed  to investigate  polyphenolic  and  sulphur  contents  of  the  aerial  parts  of
Capparis  spinosa  var.  aegyptia  (Lam.)  Boiss.,  Capparaceae,  wildly  growing  in  Egypt.  The  chemical  com-
positions  of  the  water  distilled  essential  oil  were  investigated  by  GC/MS  analysis  where  the  major
constituent  of the oil was  methyl  isothiocyanate  (24.66%).  Hydroethanolic  extract  was evaluated  by  LC-
HRESI-MS–MS  in  both  positive  and  negative  modes.  Forty-two  compounds  were  identiﬁed  including
quercetin,  kaempferol  and  isorhamnetin  derivatives  in addition  to myricetin,  eriodictyol,  cirsimaritin
and  gallocatechin  derivatives.  Quercetin  tetrahexoside  dirhamnoside  as well  as  kaempferol  dihexo-
side  dirhamnoside  have  not  been  identiﬁed  before  in  genus  Capparis.  Phenolic  acids,  such  as  quinic
acid,  p-coumaroyl  quinic  acid  and chlorogenic  acid  were  also  identiﬁed.  Evaluation  of  cytotoxic  activity
of  hydroethanolic  extract  against  three  human  cancer  cell  lines  (MCF-7;  breast adenocarcinoma  cells,ytotoxicity
Hep-G2;  hepatocellular  carcinoma  cells  and  HCT-116;  colon  carcinoma)  using  3-[4,5-dimethylthiazole-
2-yl]-2,5-diphenyltetrazolium  bromide  (MTT)  assay  showed  signiﬁcant  effect  with  IC50 values  24.5,  24.4
and  11 g/ml,  compared  to  Doxorubicin  as  a standard  cytotoxic  drug.  C.  spinosa  revealed  itself  as a
promising  candidate  for nutraceutical  researches.
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Capparaceae is a closely related family to the mustard fam-
ly (Cruciferae) with abundance of glucosinolates and ﬂavonoids
Täckholm, 1974; Inocencio et al., 2000; Kiddle et al., 2001). The
enus Capparis is represented in Egypt by six species (Täckholm,
974). Capparis spinosa var. aegyptia (Lam.) Boiss, (the caper) grow-
ng in the Egyptian deserts, is a perennial winter-deciduous plant
hat bears rounded, ﬂeshy, alternative leaves and thick, shiny, large
hite to pinkish-white complete ﬂowers. The plant is best known
or the edible bud and fruit (caper berry). In Greco-Arab and Islamic
edicine, the decoction of root bark is prescribed as deobstru-
nt to liver and spleen, as anthelmintic and anti-inﬂammatory
gents. Decoctions from the root bark have been used in traditional
edicines for dropsy, anemia, arthritis, and gout. The stem bark is
iuretic (Saad and Said, 2011). The strong ﬂavor of capers is usually
ue to the very pungent methyl isothiocyanate that is released after
n enzymatic reaction with a mustard oil glycoside named gluco-
apparin (methyl glucosinolate) (Brevard et al., 1992; Romeo et al.,
007; Sozzi et al., 2012).
∗ Corresponding author.
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C. spinosa is considered as a very important source of
medicine for antifungal (Ali-Shtayeh and Abu Ghdeib, 1999)
anti-inﬂammatory (Al-Said et al., 1988; Zhou et al., 2010), antidia-
betic, antihyperlipidemic (Eddouks et al., 2005), antihypertensive
(Baytop, 1984), antihepatotoxic (Gadgoli and Mishra, 1999), poten-
tial inhibitor of NF-kappa B (Zhou et al., 2011), and anticarcinogenic
(Kulisic-Bilusic et al., 2012).
Quantitation of ﬂavonoid content in Capers revealed it as
a very rich source of the ﬂavonols (Inocencio et al., 2000).
C. spinosa has been an interesting ﬁeld of study. Estima-
tion of phenolic compounds in the Croatian species revealed
the presence of isorhamnetin-3-O-rutinoside besides chloro-
genic acid derivatives and cinnamoyl-quinic acid derivatives
(Siracusa et al., 2011). While in China, ﬂavonoids identiﬁed
in the fruits were isoginkgetin, and ginkgetin and Sakuranetin
(Zhao et al., 2013). Egyptian species have been investigated
a long time ago. Six glucosinolates were identiﬁed, such as
glucoiberin, glucocapparin, sinigrin, glucocleomin, glucobrassicin
and glucocapangulin. Also, four ﬂavonoids were isolated from
C. cartilaginea and C. deserti and identiﬁed as kaempferol-3-
O-rutinoside, quercetin-3-O-rutinoside, quercetin-7-O-rutinoside
and quercetin-3-O-glucoside-7-O-rhamnoside (Ahmed et al.,
1972).
Besides the previously identiﬁed ﬂavonoids, Quercetin-3-O-
glucose-7-O-rhamnoside, quercetin 3-O-glucoside and quercetin
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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-O-[6′′′--l-rhamnosyl-6′′--d-glucosyl]--d-glucoside have
een identiﬁed (Sharaf et al., 1997, 2000).
Studies concerning the sulphur content of C. spinosa, revealed
he presence of butyl isothiocyanate, methyl isothiocyanate, iso-
ropyl isothiocyanate, and sec-butyl isothiocyanate (Afsharypuor
nd Jazy, 1999; Hamed et al., 2007). Nowadays, C. spinosa is also
ommercially cultivated in several countries for its fruits (Gull et al.,
015).
In the present study, the phenolic composition of the
ydroethanolic extract (HEE) was characterized using LC-HRESI-
S–MS  (liquid chromatography-high resolution electrospray
onization/mass spectrometry) and X calibur software. While
he essential oil was described using GC/MS (Gas chromatogra-
hy/mass spectrometry). In addition, cytotoxic activity of the HEE
as evaluated against different cancer cell lines.
aterial and methods
hemicals
Reagents for HPLC analysis: acetic acid and methanol were of
PLC grade and purchased from Sigma–Aldrich (Steinheim, Ger-
any).
lant material
Fresh plant material (Capparis spinosa var. aegyptia (Lam.) Boiss.,
apparaceae) was collected from Dahab, South Sinai, Egypt. The
lant was identiﬁed by Ass. Prof. Dr. Mona Marzouk, Department
f Phytochemistry and Plant Systematics, National Research Cen-
er, Egypt and a voucher specimen of the aerial parts were kept
t the herbarium of Pharmacognosy Department, Faculty of Phar-
acy, October University for Modern Sciences and Arts (no. RS 014).
he plant samples were air dried in the absence of direct sunlight
nd ground just before extraction.
xtraction of glucosinolates
Powdered air-dried aerial parts (100 g) were subjected to
ydrodistillation for 3 h using Clevenger apparatus. A yellow
olatile oil was collected 0.1 ml.  The sample oil was  collected and
reezed till GC/MS analysis (Afsharypuor and Jazy, 1999).
C–MS analysis of oil
GC–MS analysis of the volatile oil was performed using Hewlett-
ackard (HP) 6890 series (Agilent) Gas Chromatography System,
nterfaced to HP 5973 series (Agilent) mass spectrometer, equipped
ith an auto-sampler and a single capillary injector. TR-FAME
Thermo 260 M142P) (70% cyanopropyl-polysilphenylene sil-
xane) capillary GC column (30 m × 0.25 mm,  i.d., ×0.25 m ﬁlm
hickness) was used. Sample size was 1 l, oven temperature pro-
rammed from 50 to 230 ◦C at 5 ◦C/min, injector port temperature
00 ◦C, Carrier gas Helium, Flow rate was 1.5 ml  He/min. Identiﬁca-
ion of the volatile oil constituents was based on comparing their
etention times, and mass fragmentation patterns with those of the
vailable references and/or with published data (Adams, 2004) as
ell as through NIST-MS database library search. The quantitative
stimation was carried out by relative peak area measurement.reparation of the extract for LC-HRESI-MS–MS
Plant material (100 g) was exhaustively extracted with 80%
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concentrated in vacuum at 50 ◦C, dried and left for HPLC-MS–MS
analysis and cytotoxicity evaluation.
LC-HRESI-MS–MS apparatus
The analysis was  performed on a Bruker micro-TOF-Q Daltonics
(API) Time-of-Flight mass spectrometer (Bremen, Germany), cou-
pled to 1200 series HPLC system (Agilent Technologies, Waldbronn,
Germany), equipped with a high performance autosampler, binary
pump, and PDA detector G 1314 C (SL). Chromatographic separation
was performed on a Superspher 100 RP-18 (75 × 4 mm i.d.; 4 m)
column (Merck, Darmstadt, Germany).
Identiﬁcation of phenolic compounds
The method was  performed according to Hassaan et al. (2014).
Mobile phase consisted of two  solvents, (A) 2% acetic acid (pH 2.6)
and (B) 80% methanol. The separation was performed using gradi-
ent elution, from 5% to 50% B at 30 ◦C at a ﬂow rate of 100 l/min.
The ionization technique was  an ion spray (pneumatically assisted
electrospray). Spectra were recorded in positive and negative ion
mode between m/z 120 and 1500 with capillary voltage, 4000 V
and heated dry nitrogen gas temperature, 200 ◦C and ﬂow rate
10 l/min, the gas ﬂow to the nebulizer was  set at pressure 1.6 bar.
For collision-induced dissociation (CID) MS–MS  measurements, the
voltage over the collision cell varied from 20 to 70 eV. Argon was
used as collision gas. Data analysis software was used for data inter-
pretation. Sodium formate was used for calibration at the end of
LC–MS run. Interpretation for ESI-MS was  performed by Xcalibur
2.1 software from Thermo Scientiﬁc (Berlin, Germany).
Cytotoxic activity
The cytotoxicity of HEE was  assessed using MTT  (3-(4,5-
dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) assay
(Fotakis and Timbrell, 2006) against three human cancer cell lines;
breast (MCF-7), liver (HEPG-2) and colon (HCT-116) adenocarci-
noma using Doxorubicin® as reference standard. Dose dependent
activities were studied from 5 to 50 g/ml, and the IC50 values
(concentration which reduced survival to 50%) were estimated
from graphic plot. Three separate experiments were performed for
each sample.
Results and discussion
GC–MS analysis of the volatile oil
The oil of the dried aerial parts of C. spinosa was obtained by
water distillation with yields 0.1% w/v. The oil was dark yellow col-
ored showing a strong aromatic odor. GC–MS analysis revealed the
identiﬁcation of twenty-six components (Table 1) amounting for
(95.46%) of the oil. The sulfated compounds were present in a rela-
tively high percentage (40.3%), which are responsible for the aroma
of C. spinosa volatile oil. Methyl isothiocyanate was the major con-
stituent representing 24.66%. Components of the oil, their relative
retention times and area percentages were compiled in Table 1.
The results of our analyses were in agreement and consistent with
those reported previously by Kulisic-Bilusic et al. (2012), where
methyl isothocyanate was  the major component of the volatile oil
of C. spinosa collected from central Dalmatia. Phenyl propanoid, ter-
penoids, isothiocyanate, and n-alkalenes were revealed also as part
of the C. spinosa oil (Ahmed et al., 1972).
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Table  1
GC–MS analysis of the volatile oil constituents of the aerial parts of C. spinosa.
Peak no. Identiﬁed compound RRta Area%
1 Isopropyl isothiocyanate 0.72 12.44
2  p-Cymene 0.84 2.93
3  Methyl isothiocyanate 1 24.66
4  Butyl isothiocyanate 1.17 3.2
5  -Copaene 1.49 4.57
6  Thujone 1.71 1.81
7  Caryophyllene 1.98 2.91
8  Camphor 2.11 1.66
9  Humulene 2.23 4.24
10  1,2,3,5,6,8a-Hexahydro-4,7-dimethyl-1-(1-methylethyl)-naphthalene 2.27 5.56
11  -Muurolene 2.31 2.6
12  Unidentiﬁed 2.41 1.17
13  3-Cyclohexen-1-one 2.82 1.21
14  3-Methyl-4-isopropylphenol 3.67 3.98
15  Spathulenol 3.69 1.47
16  Muurolol 3.76 2.42
17  6,10-Dimethyl-2-undecanone 3.84 6.5
18  -Cadinol 3.89 4.26
19 Unidentiﬁed 3.91 1.84
20  Unidentiﬁed 4.03 0.78
21  Tetracosane 4.22 0.55
22  Eicosane 4.46 1.3
23  Unidentiﬁed 4.54 0.75
24  Heptacosane 4.92 2.58
25  1-Naphthalenepropanol 4.99 0.58
26  2-Cyclohexen-1-ol 5.01 0.56
27  1,2-Benzenedicarboxylic acid 5.07 0.91
28  Isobutyl 2-methylpent-3-yl ester 5.35 1.07
29  Phenanthrene 5.45 1.02
30  Dibutyl phthalate 6.24 0.46
Percentage of identiﬁed constituents 95.46%
Percentage of unidentiﬁed constituents 4.54%
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a RRt, relative retention time to: methyl isothiocyanate = 6.99 min.
C-HRESI-MS–MS analysis of phenolic compounds
LC–MS analysis demonstrated the presence of highly glyco-
ylated ﬂavonol in addition to ﬂavone glycosides and phenolic
cid derivatives as previously reported in different caper extract
Inocencio et al., 2000). In total, 42 compounds belonging to differ-
nt classes were identiﬁed by LC–MS/MS-HR-ESI in the HEE of the
erial parts of C. spinosa. Data concerning the identiﬁcation of the
eaks are shown in Table 2, in which we report the retention time,
lectrospray ionization mass spectrometry in negative and posi-
ive ion mode for all of the compounds detected. The structures of
nknown phenolic acids or ﬂavonoids were assessed based on the
/z of both precursor ion and fragment ion obtained. Moreover, the
pectral data were compared with that reported in the literature.
Flavonoids were the major identiﬁed components with pre-
ominance of ﬂavonol class especially quercetin derivatives
ﬁfteen compounds). New compounds were identiﬁed such as
uercetin tetrahexoside and quercetin tetrahexoside dirhamno-
ide. Kaempferol derivatives have been also identiﬁed (seven
ompounds), isorhamnetin derivatives (six compounds) in addition
o myricetin, eriodictyol, cirsimaritin and gallocatechin derivatives.
ugar moieties consist of hexosides, deoxyhexosides and pento-
ides as deduced from the loss of 162, 146 and 132 u respectively
Ibrahim et al., 2015).
Quercetin (compound 26) was tentatively identiﬁed with its
ase peak at m/z 271.15 and characteristic peaks at m/z 255, 179 and
51 (Martucci et al., 2014), Quercetin tetrahexoside (compound 7),
entatively identiﬁed for the ﬁrst time in this genus, showed a pre-
ursor ion at m/z  949.24 [M−H] and the MS/MS  led to a product
on at m/z 301.16 denoting a quercetin derivative. In the positive
onization, precursor ion peak appeared at m/z 951.26 with prod-
ct ions at 789.24 (M+H-hexose), 627.34 (M+H-dihexose), 465.23Methyl isothiocyanate
(M+H-trihexose) and 303.19 (M+H-tetrahexose) and denoting the
quercetin.
Compound 11, was tentatively identiﬁed as quercetin trihexo-
side rhamnoside with a precursor ion peak at 933.25 [M−H] and
product ion peak at m/z 609.28 [M−H-dihexose]. Positive ioniza-
tion showed a precursor ion at [M+H] at m/z 935.26 with product
ions at 789.1 [M+H-rhamnose], 627.09 [M+H-rhamnose-hexose],
465.15 [M+H-rhamnose-dihexose] and 303.13 [M+H-rhamnose-
trihexose]. Compound 20, tentatively identiﬁed as quercetin
dirhamnoside hexoside showed a precursor ion peak at m/z 755.2
[M−H] with product ions at m/z 593.3 [M−H-hexose], 447.1
[M−H-hexose-rhamnose], 301.2 [M−H-hexose-dirhamnose] and
a characteristic peak for quercetin at 271.21. Positive ionization
showed similar fragmentation with [M+H] at m/z 757.22.
Compound 34, with a precursor ion peak [M−H] at m/z  1095.25
and [M+H] at m/z 1097.32 showed product ion peaks at m/z  936.39
[M+H-hexose], 773.31 [M+H-dihexose], 627.19 [M+H-dihexose-
rhamnose], 465.11 [M+H-trihexose-rhamnose], 303.07 [M+H-
tetrahexose-rhamnose] was tentatively identiﬁed as quercetin
tetrahexoside rhamnoside. Compound 40 tentatively identiﬁed
as quercetin dihexoside dirhamnoside, showed a precursor ion
peak [M−H] at m/z 917.23 and positive ionization [M+H] at m/z
919.27 with product ion peak at 611.14 [M+H-hexose-rhamnose],
465.15 [M+H-hexose-dirhamnoside] and 303.19 [M+H-dihexose-
dirhamnoside].
Kaempferol is the second major identiﬁed ﬂavonoid (compound
15) with [M−H] at m/z 285.04 and differentiated from luteolin
by the presence of characteristic peaks at m/z 213.13 (Cuyckens
and Claeys, 2004). Several kaempferol derivatives were identiﬁed,
however, compound 36, tentatively identiﬁed as kaempferol ruti-
noside hexoside was not identiﬁed before in C. spinosa and showed
[M-H] at m/z 755.2 and positive ionization [M+H] at m/z  757.22
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Table  2
Peak assignment of metabolites in hydroethanolic extract of C. spinosa using LC-HRESI-MS–MS in the negative and positive modes.
No Rt (min) Compounds [M−H]−
m/z
Negative ionization
MS/MS
[M+H]+ m/z Positive ionization References
1 1.71 Gluconic acid 195.05 195.05 129.07 177.1
159.07 99.07
197.08 197.08 179.09 135.10 Felipe et al. (2014)
2 1.89 Quinic acid 191.02 191.02 111.08 173.04 193.05 193.05 175.01 161.11
147.04 133.03
3  22.23 Chlorogenic acid 353.09 353.09 191.11 269.21
293.2 179.19
355.12 355.10 337.19 193.06
201.04 267.01
Martucci et al. (2014)
4 30.34 Kaempferol-O-
glucoside
447.09 447.09 285.14
(M−H-hex) 325.21
327.21
449.11 449.11 287.11 Rodrigo et al. (1992)
5 45.23 Quercetin-O-glucoside 463.09 463.09 301.19
(M−H-hex) 343.16
(M−H-120)
465.10 465.10 303.10 287.13 Martucci et al. (2014)
6 33.31 p-Coumaroyl quinic
acid
337.06 337.06 191.16 179.15
135.22 293.2
339.10 339.10 320.22 293.14
279.11 206.18 176.16
130.1
Martucci et al. (2014)
7 33.81 Quercetin
tetrahexoside
949.24 949.24 625.30
(M−H-dihexose)
301.16
(M−H-tetrahexose)
787.40 (M−H-hexose)
463.25
(M−H-trihexose)
951.26 951.26 931.43 789.24
(−162) 627.34 (−162)
465.23 (−162) 303.19
(−162)
8  34.97 Quercetin trihexoside 787.3 787.3 621.29 625.39
(M−H-hexose) 463.31
(M−H-dihexose)
301.24
(M−H-trihexose)
789.23 789.23 303.14 627.23
(M+H-hex) 465.17
(M+H-dihex)
Qu et al. (2013)
9 35.43 Epigallocatechin
hexoside
467.12 467.12 305.24 469.17 469.17 307.02 435.91
169.07 144.05 289.24
10  35.81 Quercetin rhamnoside
hexoside
609.15 609.15 301.21
(M−H-Rh-hex) 447.28
(M−H-hex) 549.28
271.21 255.09 179.1
611.16 611.16 303.12
(M+H-rh-hex) 465.06
(M+H-rh)
Falé et al. (2013)
11 36.20 Quercetin trihexoside
rhamnoside
933.25 933.25 609.28
(M−H-dihex) 301.17
(609-rh-hex)
935.26 935.26 789.1 (M+H-rh)
627.09 (M+H-rh-hex)
465.16 (M+H-rh-dihex)
303.13
(M+H-rh-trihex)
12  36.73 Acacetin hexoside 445.21 445.21 385.27 283.19 447.23 447.23 225.04 386.94
429.25 207.15 189.23
Lin and Harnly (2010)
13 54.70 Kaempferol 285.04 285.04 255.11 241.22
229.18 213.13 163.2
151.13 96.97
287.08 287.08 241.11 269.19
213.07 164.99 152.99
133.05 121.05
Martucci et al. (2014)
14 39.17 Eriodictyol hexoside 449.11 449.11 287.15
(M−H-hex) 387.28
281.23 151.09 137.15
451.12 451.12 289.15
(M+H-hex) 433.22
268.08
Zhao et al. (2013)
15 39.38 Isorhamnerin hexoside
rutinoside
785.11 785.11 623.28
(−M−H-hex) 315.12
(M−H-hex-rh-hex)
787.23 787.23 317.21
(M+H-rh-dihex) 641.13
(M+H-rh) 479.15
(M+H-rh-hex)
Kim and Park (2009)
16 40.23 Eriodictyol-7-O-
rutinoside
595.17 595.17 287.11
(M−H-rutinose)
597.18 597.18 435.08
(M+H-hex) 289.14
(M+H-hex-rh) 577.26
451.07 399.2
Zhao et al. (2013)
17 40.27 Eriodictyol 287.06 287.06 151.08 125.18
135.07
289.07 289.07 163 271.13
152.98 179.03 143.96
Zhao et al. (2013)
18 41.5 Eriodictyol glucuronide 463.09 463.09 287.18 301.17
403.23 311.26 175.09
151.09
Li et al. (2012)
19 43.21 Quercetin
glucoside-O-rutinoside
771.2 771.2 609.15 (-hex)
463.21 (-rh) 301.26
(-rh)
773.21 773.21 465.18 611.10
303.14 627.15
Sharaf et al. (2000)
20 43.91 Quercetin
dirhamnoside hexoside
755.2 755.2 593.3 (-hex)
447.1 (-rh) 301.2 (-rh)
271.21
757.22 757.22 624.16 595.37
611.16 449.24 303.14
287.21
21  44.62 Myricetin rutinoside 625.14 625.14 316.1 317.16
(M−H-rh-hex) 285.12
271.20 479.20
(M−H-rh) 607.26
179.08
62.16 627.16 319.12
(M+H-rh-hex) 464.22
481.11 (M+H-rh)
Sójka et al. (2009)
22 44.82 Cirsimaritin hexoside
rhamnoside
621.15 621.15 313.15
(M−H-rh-hex) 285.2
257.3
623.16 623.16 477.09
(M+H-rh) 315.11
(M+H-162)
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Table  2 (Continued)
No Rt (min) Compounds [M−H]−
m/z
Negative ionization
MS/MS
[M+H]+ m/z Positive ionization References
23 59.85 Isorhamnetin hexoside 477.27 477.27 315.34
(M−H-hex)
479.12 479.12 317.09
(M+H-hex) 301.15
360.86 419.93 459.27
24  45.53 Isorhamnetin
dihexoside
dirhamnoside
931.27 931.27 767.38
(M−H-hex) 621.35
(M−H-hex-rh) 315.19
300.08 357.35 785.40
933.29 933.29 317.21
(M+H-dirh-dihex)
914.45 771.29
(M+H-hex) 769.29
625.22 (M+H-hex-rh)
463.2 (M+H-rh-dihex)
25  46.75 Gallocatechin 305.07 305.07 290.23 97.01
225.13 275.22 259.21
307.11 307.11 130.06 289.18
262.15 242.16 204
307.13 265.16 289.20
247.17 178.12 144.11
Hossain et al. (2010)
26 47.64 Quercetin 301.04 301.04 271.15 255.15
257.22 179.15 151.1
229.93
303.04 303.04 285.05 302.85 Martucci et al. (2014)
27 47.9 Quercetin-3-O-hexose-
O-pentoside
595.13 595.13 301.16
(M−H-hex-pen) 285.14
271.22 433.43
(M−H-hex) 463.27
191.16 179.13
597.15 597.15 303.12
(M+H-pen-hex) 287.12
465.10 (M+H-pen)
449.11
Martucci et al. (2014)
28 48.19 Kaempferol hexoside
dirhamnoside
739.21 739.21 575.3 649.43
429.29 284.18 255.1
741.22 741.22 595.05
(M+H-rh) 449.07
(M+H-dirh) 287.13
(M+H-dirh-hex)
Rodrigo et al. (1992)
29 48.50 Apigenin 8C-glucoside 431.1 431.1 311.22
(M−H-120) 341.18
(M−H-90) 413.21
312.18
433.11 433.11 415.23 313.16
(M+H-120) 397.23
367.18 271.16
(M+H-hex)
Abad-García et al. (2008)
30 49.05 Kaempferol hexoside
rhamnoside
593.15 593.15 285.21
(M−H-308) 473.24
(M−H-120) 503.24
(M−H-90)
595.16 595.16 287.05
(M+H-rh-hex) 449.11
(M+H-rh) 576.38
431.24
Ferreres et al. (2011)
31 49.36 Isorhamnetin 3-O
rutinoside
623.16 623.16 315.22
(-rutinose) 314.15
459.2 460.38 503.14
(−120)
625.18 625.18 317.12
(M+H-rh-hex) 479.02
(M+H-rh)
Roriz et al. (2014)
32 50.00 Quercetin dihexoside 625.14 625.14 301.2
(M−H-dihex) 463.14
(M−H-hex) 285.26
271.2
627.16 627.16 465.11
(M+H-hex) 303.10
(M+H-dihex)
Tedesco et al. (2015)
33 51.22 Kaempferol
glucuronide
461.07 461.07 285.18 381.27 463.09 463.09 343.14 427.21
299.11 268.23
Martucci et al. (2014)
34 51.90 Quercetin
tetrahexoside
rhamnoside
1095.29 1095.29 609.3 (rutin)
787.28 (M−H-hex-rh)
483.2 933.44
(M−H-hex) 302.33
1097.32 1097.32 627.19
(M+H-rh-dihex) 936.39
(M+H-hex) 773.31
(M+H-dihex) 465.11
(M+H-trihex-rh)
303.07
(M+H-tetrahex-rh)
449.19 (Q-rh) 611.09
(rutin) 787.39
35  54.13 Isorhamnetin 315.1 315.1 271.2 285.18
287.11 300.11
317.07 317.07 302.09 285.1
271.13 257.12 165.07
139.02
Sánchez-Rabaneda et al. (2004)
36 54.24 Kaempferol rutinoside
hexoside
755.2 755.2 285.15
(M−H-hex-rh) 593.32
(M−H-hex)
757.22 757.22 449.12
(M+H-hex-rh) 595.15
(M+H-hex) 611.10
(M+H-rh) 287.09
(M+H-trihex-rh)
37  54.49 Myricetin hexoside
rutinoside
787.17 787.17 625.24
(M−H-hex) 479.23
(M−H-hex-rh) 317.21
(M−H-dihex-rh)
789.19 789.19 481.14
(M+H-hex-rh) 319.2
(M+H-dihex-rh)
38  55.18 Isorhamnetin
glucuronide
491.08 491.08 315.20 493.1 493.1 317.16 Duen˜as et al. (2008)
39 55.47 Quercetin acetyl
hexoside
505.13 505.13 353.29 459.29
485.31 323.24 301.20
151.03 179.12 191.09
Navarro-González et al. (2015)
40 58.05 Quercetin dihexoside
dirhamnoside
917.23 917.23 609.31
(M−H-308) 301.16
(M-H-308)
919.27 919.27 611.14
(M+H-308) 465.15
(M+H-rh) 449.16
303.19 (M+H-hex)
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Table  2 (Continued)
No Rt (min) Compounds [M−H]−
m/z
Negative ionization
MS/MS
[M+H]+ m/z Positive ionization References
41 60.68 Myricetin hexoside 479.16 479.16 317.18
(M−H-hex) 273.18
258.29 447.31 461.34
389.12 (M−H-90)
359.28 (M−H-120)
481.19 481.19 319.17
(M+H-hex) 464.25
302.14 285.21 191.14
Raal et al. (2015)
42 62.14 Kaempferol dihexoside
dirhamnoside
901.24 901.24 593.23
(M−H-rh-hex) 285.2
(M−H-dirh-dihex)
739.44 (M−H-hex)
903.27 903.27 884.47
(M+H-H2O) 287.16
(M+H-dirh-hex) 757.16
(M+H-hex) 595.23
(M+H-rh-hex) 449.08
(M+H-dirh-hex)
rh, rhamnose; hex, hexose; Q, quercetin; pen, pentose.
Fragment ions are listed in order of relative abundances. Ions in boldface indicate the most intense product ion (100% relative intensity).
Table 3
Cytotoxic activity of the HEE of the aerial parts of Capparis spinosa and Doxorubicin standard against human breast adenocarcinoma cells (MCF-7), hepatocellular carcinoma
cells  (Hep-G2) and colon carcinoma cells (HCT-116).
Cell line MCF-7 Hep-G2 HCT-116
C. spinosa HEE Doxorubicin C. spinosa HEE Doxorubicin C. spinosa HEE Doxorubicin
 ± 1.87
D triplic
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e
i
i
h
w
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i
h
[
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s
S
a
i
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t
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p
a
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a
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a
[
2
q
The authors are thankful to Prof. Dr. Nahla Ayoub, professor ofIC50 (g/ml) 24.5 ± 2.23 0.426 ± 0.35 24.4
ata are presented as mean ± SD of IC50 (g/ml) from 3 independent experiments, 
ith product ion peaks at 611.10 [M+H-rhamnose], 449.12 [M+H-
hamnose-hexose] and 287.09 [M+H-rhamnose-dihexose].
Compound 42, identiﬁed as kaempferol dihexoside dirhamno-
ide, showed a precursor ion peak [M-H] at m/z 901.24 and positive
onization [M+H] at m/z 903.27 with product ions at m/z 757.16
M+H-rhamnose], 595.23 [M+H-rhamnose-hexose], 449.08 [M+H-
irhamnose-hexose] and 287.16 [M+H-dirhamnose-dihexose].
Isorhamnetin has been previously identiﬁed in Capparis, how-
ver, its derivatives have not. Compound 15, with a precursor
on [M-H] at m/z 785.11 and [M+H] at m/z  787.23 and daughter
on peak at 641.13 [M+H-rhamnose], 479.15 [M+H-rhamnose-
exose] and base peak at m/z  317.21 [M+H-rhamnose-dihexose]
as identiﬁed as Isorhamnetin hexoside rutinoside. Compound
3 was tentatively identiﬁed as isorhamnetin hexoside with
M−H] at m/z 477.27 while compound 24, tentatively identiﬁed
s isorhamnetin dihexoside dirhamnoside with a precursor ion
eak [M−H] at m/z  931.27 and [M+H] at m/z 933.29, product ions
n the positive ionization at 771.29 [M+H-hexose], 625.22 [M+H-
exose-rhamnose], 463.2 [M+H-dihexose-rhamnose] and 317.21
M+H-dihexose-dirhamnose].
These results were in agreement with Gull et al. (2015) and
ehnaz et al. (2013) who reported C. spinosa leaves to be a good
ource of kaempferol, quercetin, rutin and isorhamnetin. While
iracusa et al. (2011) reported rutin, kaempferol, 3-O-rutinoside,
nd isorhamnetin 3-O-rutinoside as major ﬂavonoids in C. spinosa.
Myricetin and its derivatives have not been previously identiﬁed
n Capparis, however, it was tentatively identiﬁed with its charac-
eristic peak at m/z  317 in the negative ionization and m/z 319 in
he positive ionization.
Flavones were also present. Compound 29, was identiﬁed as api-
enin 8-C-glucoside with precursor ion at m/z 433 [M+H] in the
ositive ionization mode. The product ions obtained with cleav-
ge of sugar ring have been proposed as diagnostic ions, where
/z 313 is observed and m/z 283 diagnostic of 6-C-glucoside is
bsent (Abad-García et al., 2008). C-glycosyl ﬂavones produces MS
ragmentation pattern including dehydration and cross ring cleav-
ge of the glucose moiety that produces 0,2 cross ring cleavage
M−H-120] and 0,3 cross ring cleavage [M−H-90] (Martucci et al.,
014).Phenolic acids were also identiﬁed as quinic acid, p-coumaroyl
uinic acid and chlorogenic acid. 0.467 ± 0.2 11 ± 1.54 0.23 ± 0.17
ate for each.
Cytotoxic activity of the HEE
HEE of C. spinosa showed promising cytotoxic activity. In the US
National Cancer Institute Plant Screening Program, a crude extract
is generally considered to have in vitro cytotoxic activity if the IC50
value in carcinoma cells, following incubation between 48 and 72 h,
is less than 20 g/ml (Boik, 2001). HCT-116 was found to be the
most sensitive to HEE with cell viability less than 50% at the con-
centration of 11 ± 1.54 g/ml. Investigation showed difference in
sensitivity of different cancerous cells to the Capparis extract as
has been observed with many other species (Fouche et al., 2008).
Potency against different cancer cell lines was presented in Table 3.
Flavonoids have been reported to exhibit prooxidant cytotoxicity
against cancer cells through the ROS-triggered mitochondrial apop-
totic pathway, therefore, responsible for the promising cytotoxicity
of C. spinosa against various cancer cell lines (Zhang et al., 2015).
Conclusion
C. spinosa is a rich source, not only of sulphur compounds, but
also with phenolic and ﬂavonoid glycosides contributing to its
powerful cytotoxic activity. C. spinosa is suggested to be a good
candidate for use in natural medicine with historical background.
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